These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24419516)

  • 1. Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage.
    Lown RN; Marsh SG; Switzer GE; Latham KA; Madrigal JA; Shaw BE
    Bone Marrow Transplant; 2014 Apr; 49(4):525-31. PubMed ID: 24419516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Race/Ethnicity in Donor Decisions about Unrelated Hematopoietic Progenitor Cell Donation: Exploring Reasons for Higher Attrition among Racial/Ethnic Minorities.
    Anthias C; Shaw BE; Bruce JG; Confer DL; Abress LK; Dew MA; Billen A; O'Leary A; Braund H; Switzer GE
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):593-599. PubMed ID: 31654786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvest.
    Lown RN; Tulpule S; Russell NH; Craddock CF; Roest R; Madrigal JA; Shaw BE
    Haematologica; 2013 Dec; 98(12):1956-63. PubMed ID: 23812935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attrition at the final donor stage among unrelated haematopoietic stem cell donors: the British Bone Marrow Registry experience.
    Balassa K; Griffiths A; Winstone D; Li Y; Rocha V; Pawson R
    Transfus Med; 2019 Oct; 29(5):332-337. PubMed ID: 31209947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated with Opting Out of Donation among Registered Young Unrelated Hematopoietic Stem Cell Donors.
    Hamed AB; Bruce JG; Kuniyil V; Mattila D; Williams EP; Dew MA; Myaskovsky L; Confer DL; Switzer GE
    Transplant Cell Ther; 2023 Mar; 29(3):177.e1-177.e22. PubMed ID: 36455856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision.
    Lown RN; Shaw BE
    Bone Marrow Transplant; 2013 Feb; 48(2):210-9. PubMed ID: 22484322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with registrant availability for unrelated adult donor hematopoietic stem cell donation: Analysis of the stem cell registry at Canadian Blood Services.
    Monaghan M; Yi QL; Green M; Campbell T; Weiss JT; Dibdin N; Mercer D; Elmoazzen H; Allan DS
    Transfusion; 2021 Jan; 61(1):24-28. PubMed ID: 33084098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of DPB1 Permissive Unrelated Donors Is Highly Likely.
    Tram K; Stritesky G; Wadsworth K; Ng J; Anasetti C; Dehn J
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):81-86. PubMed ID: 27989930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes from unrelated donor hematopoietic stem cell transplantation.
    Perez LE
    Cancer Control; 2011 Oct; 18(4):216-21. PubMed ID: 21976240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motives for joining an unrelated HSC donor registry: description, categorization, and association with donor availability.
    La Casta AH; Shaw BE; Anthias C; Bruce JG; Pastorek G; Billen A; O'Leary A; Switzer GE
    Bone Marrow Transplant; 2019 Mar; 54(3):425-431. PubMed ID: 30087465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization.
    Pidala J; Kim J; Schell M; Lee SJ; Hillgruber R; Nye V; Ayala E; Alsina M; Betts B; Bookout R; Fernandez HF; Field T; Locke FL; Nishihori T; Ochoa JL; Perez L; Perkins J; Shapiro J; Tate C; Tomblyn M; Anasetti C
    Bone Marrow Transplant; 2013 Mar; 48(3):346-50. PubMed ID: 22863723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Providing Level-of-Match Information to Perfectly Matched Unrelated Stem Cell Donors: Evaluating Acceptability and Potential Changes in Donor Availability.
    Switzer GE; Macis M; Fabi R; Abress L; Confer D; Bruce J; Howe K; Fowler S; McNulty M; Pastorek G; Dew MA
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):2110-2118. PubMed ID: 29574124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using EasyMatch® to anticipate the identification of an HLA identical unrelated donor: A validated efficient time and cost saving method.
    Dubois V; Detrait M; Sobh M; Morisset S; Labussière H; Giannoli C; Nicolini F; Moskovtchenko P; Mialou V; Ducastelle S; Rey S; Thomas X; Barraco F; Tedone N; Marry E; Garnier F; Bertrand Y; Michallet M
    Hum Immunol; 2016 Nov; 77(11):1008-1015. PubMed ID: 26902994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selection of an unrelated donor for hematopoietic stem cell transplantation. HLA haplotypes in patients with blood system diseases].
    Khamaganova EG; Parovichnikova EN; Kuz'mina LA; Gemdzhian ÉG; Chugreeva TP; Iushkova AA
    Ter Arkh; 2014; 86(7):31-6. PubMed ID: 25314775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia.
    Segal E; Martens M; Wang HL; Brazauskas R; Weisdorf D; Sandmaier BM; Khoury HJ; de Lima M; Saber W
    Cancer; 2017 Sep; 123(17):3346-3355. PubMed ID: 28452054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimedia resources to support the recruitment of committed hematopoietic stem cell donors: Perspectives of the most-needed donors.
    Li EW; Lee A; Vaseghi-Shanjani M; Anagnostopoulos A; Jagelaviciute G; Kum E; Petraszko T; Elmoazzen H; Allan D; Fingrut W
    Transfusion; 2021 Jan; 61(1):274-285. PubMed ID: 33269472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection.
    Greco-Stewart V; Kiernan J; Killeen D; Haun S; Mercer D; Young K; Liwski RS; Allan DS
    Transfusion; 2018 Mar; 58(3):718-725. PubMed ID: 29277913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.
    Frick M; Chan W; Arends CM; Hablesreiter R; Halik A; Heuser M; Michonneau D; Blau O; Hoyer K; Christen F; Galan-Sousa J; Noerenberg D; Wais V; Stadler M; Yoshida K; Schetelig J; Schuler E; Thol F; Clappier E; Christopeit M; Ayuk F; Bornhäuser M; Blau IW; Ogawa S; Zemojtel T; Gerbitz A; Wagner EM; Spriewald BM; Schrezenmeier H; Kuchenbauer F; Kobbe G; Wiesneth M; Koldehoff M; Socié G; Kroeger N; Bullinger L; Thiede C; Damm F
    J Clin Oncol; 2019 Feb; 37(5):375-385. PubMed ID: 30403573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.
    Auletta JJ; Novakovich JL; Stritesky GL; Newman J; Fridy-Chesser ST; Hailperin K; Devine SM
    Transplant Cell Ther; 2021 Feb; 27(2):133-141. PubMed ID: 33830022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.
    Kollman C; Spellman SR; Zhang MJ; Hassebroek A; Anasetti C; Antin JH; Champlin RE; Confer DL; DiPersio JF; Fernandez-Viña M; Hartzman RJ; Horowitz MM; Hurley CK; Karanes C; Maiers M; Mueller CR; Perales MA; Setterholm M; Woolfrey AE; Yu N; Eapen M
    Blood; 2016 Jan; 127(2):260-7. PubMed ID: 26527675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.